remifentanil hydrochloride
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
8 FDA-registered drug labelers
American Pacific Corporation
Cilag AG
Fine Chemicals Corporation (PTY) Ltd.
Fresenius Kabi USA, LLC
Hikma Pharmaceuticals USA Inc.
Mylan Institutional LLC
Navinta LLC, NJ, USA
Veranova, L.P.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Remifentanil Hydrochloride
- •Ultiva
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
Active Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
current
Remifentanil Hydrochloride Injection
06/28/2022Unavailable
current
Remifentanil Hydrochloride Injection
06/28/2022Available
Chemical Identity
CAS132539-07-2
PubChem CID60814
DTXSIDDTXSID50157614
FormulaC20H29ClN2O5
Mol. Weight412.9 g/mol
SMILESCCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC.Cl
Data Sources
608142026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/remifentanil hydrochloride/cids/JSON
Archive: data/sources/pubchem_name/remifentanil hydrochloride.json
CAS 132539-07-22026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 132539-07-22026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json